Legend Biotech (LEGN) Other Non Operating Income (2020 - 2025)

Legend Biotech has reported Other Non Operating Income for 6 years, with the latest figure at -$2.4 million in Q4 2025.

• For the quarter ending Q4 2025, Other Non Operating Income fell 102.15% year-over-year to -$2.4 million; the trailing twelve-month figure through Dec 2025 stood at -$55.0 million (down 149.15% YoY), and the FY2025 full-year result was -$164.8 million, down 247.41% from the prior year.
• Other Non Operating Income for Q4 2025 stood at -$2.4 million, down from $354000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $111.4 million in Q4 2024, with the low at -$108.1 million in Q2 2025.
• Historically, Other Non Operating Income has averaged $6.7 million across 5 years, with a median of $3.6 million in 2021.
• Annual changes were most pronounced in 2021 — Other Non Operating Income jumped 7474.24% — and 2025, when it sank 969.55%.
• Legend Biotech's Other Non Operating Income stood at $4.9 million in 2021, then jumped by 88.19% to $9.2 million in 2022, then soared by 318.52% to $38.3 million in 2023, then jumped by 190.62% to $111.4 million in 2024, then slumped by 102.15% to -$2.4 million in 2025.
• The last three Other Non Operating Income figures came in at -$2.4 million (Q4 2025), $354000.0 (Q3 2025), and -$108.1 million (Q2 2025), per Business Quant data.